Vyome Holdings, Inc (HIND) stock
HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.03 (-2.27%)
Close on Nov 18, 2026Market cap $10.60MP/E –Yield –
Vyome revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Vyome's revenue for the twelve months ending Jun 30, 2026 was $129.72K, down 67.1% year over year. For fiscal 2025 it was $319.71K, up 24.4% from the year before. Over ten years it grew -22.4% a year on average. The highest annual figure on record is $13.60M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $319.71K | +24.4% |
| FY2024 | Dec 31, 2024 | $256.94K | -97.0% |
| FY2023 | Dec 31, 2023 | $8.68M | -22.8% |
| FY2022 | Dec 31, 2022 | $11.24M | -17.4% |
| FY2021 | Dec 31, 2021 | $13.60M | +20.4% |
| FY2020 | Dec 31, 2020 | $11.30M | +244.4% |
| FY2019 | Dec 31, 2019 | $3.28M | -63.9% |
| FY2018 | Dec 31, 2018 | $9.10M | -8.2% |
| FY2017 | Dec 31, 2017 | $9.91M | +192.2% |
| FY2016 | Dec 31, 2016 | $3.39M | -16.0% |
| FY2015 | Dec 31, 2015 | $4.04M | +14.1% |
| FY2014 | Dec 31, 2014 | $3.54M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.96K | -46.0% |
| Q1 FY2026 | Mar 31, 2026 | $31.59K | -84.1% |
| Q4 FY2025 | Dec 31, 2025 | $36.55K | -40.5% |
| Q3 FY2025 | Sep 30, 2025 | $34.63K | -59.0% |
| Q2 FY2025 | Jun 30, 2025 | $49.95K | -97.5% |
| Q1 FY2025 | Mar 31, 2025 | $198.58K | -89.8% |
| Q4 FY2024 | Dec 31, 2024 | $61.43K | -96.9% |
| Q3 FY2024 | Sep 30, 2024 | $84.53K | -96.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.97M | -12.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.94M | -15.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.98M | -36.3% |
| Q3 FY2023 | Sep 30, 2023 | $2.16M | -23.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.25M | -22.1% |
| Q1 FY2023 | Mar 31, 2023 | $2.29M | -6.3% |
| Q4 FY2022 | Dec 31, 2022 | $3.11M | -1.0% |
| Q3 FY2022 | Sep 30, 2022 | $2.80M | -24.5% |
| Q2 FY2022 | Jun 30, 2022 | $2.89M | -18.1% |
| Q1 FY2022 | Mar 31, 2022 | $2.44M | -24.2% |
| Q4 FY2021 | Dec 31, 2021 | $3.14M | -2.0% |
| Q3 FY2021 | Sep 30, 2021 | $3.71M | +2.9% |
| Q2 FY2021 | Jun 30, 2021 | $3.53M | +107.3% |
| Q1 FY2021 | Mar 31, 2021 | $3.22M | +312.9% |
| Q4 FY2020 | Dec 31, 2020 | $3.21M | +307.5% |
| Q3 FY2020 | Sep 30, 2020 | $3.60M | +981.7% |
| Q2 FY2020 | Jun 30, 2020 | $1.70M | +340.9% |
| Q1 FY2020 | Mar 31, 2020 | $780.00K | -56.1% |
| Q4 FY2019 | Dec 31, 2019 | $787.00K | -61.3% |
| Q3 FY2019 | Sep 30, 2019 | $333.00K | -88.9% |
| Q2 FY2019 | Jun 30, 2019 | $386.00K | -85.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.78M | +31.9% |
| Q4 FY2018 | Dec 31, 2018 | $2.04M | -44.9% |
| Q3 FY2018 | Sep 30, 2018 | $2.99M | +7.2% |
| Q2 FY2018 | Jun 30, 2018 | $2.73M | +39.2% |
| Q1 FY2018 | Mar 31, 2018 | $1.35M | -8.6% |
| Q4 FY2017 | Dec 31, 2017 | $3.69M | +378.2% |
| Q3 FY2017 | Sep 30, 2017 | $2.79M | +260.5% |
| Q2 FY2017 | Jun 30, 2017 | $1.96M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.47M | – |
| Q4 FY2016 | Dec 31, 2016 | $772.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $773.00K | – |
See a number that looks wrong?